Intervention: Nutrafol Men (n = 47) or Nutrafol Women (n = 51).
Methods: Subjects were evaluated clinically at baseline, week 12 and week 24. Evaluation included an investigator assessment of hair growth, coverage, density, and volume. Self-assessment questionnaires were used to evaluate hair growth and quality. Hair satisfaction and lifestyle factors (e.g., mood, confidence) were also evaluated.
Study Duration: 6 months
Eligibility Criteria:
Investigator ratings for baseline overall growth, coverage, density and volume were significantly improved at week 12 and week 24 for all subjects (P<0.001). The composite measure revealed that 83.7% of males and 79.5% of females exhibited significant improvements after 24 weeks of treatment (P<0.001 for both groups vs. baseline).
Percentage of subjects who exhibited an improvement in their hair, based on the composite endpoint of investigator rated standardized global images.
Self-assessment outcomes were in agreement with the investigator ratings. All subjects reported significant improvements in appearance/quality, volume/fullness, coverage of the scalp, thickness and lack of shedding at week 4, week 8, week 12 and week 24 (P<0.01 for each vs. baseline).
No unanticipated adverse events and no serious treatment-emergent adverse events were reported.
This information is provided as a medical and scientific educational resource for the use of dieticians and other licensed healthcare professionals. This information is intended for Practitioners to use as the basis for determining whether to recommend these products to their clients. All recommendations regarding protocols, dosing, prescribing and/or use instructions should be tailored to the individual needs of the client considering their medical history and concomitant therapies. This Information is not intended for use by consumers.
© 2025 Unilever.
All rights reserved
